On December 13, 2019, the State Securities Commission issued a document allowing DHG Pharmaceutical Joint Stock Company to extend submission date of financial statements.    

-           For the quarterly financial statements: within 30 days from the last day of quarter;

-           Audited annual financial statements: within 100 days from the last day of fiscal year.